SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-013068
Filing Date
2023-02-21
Accepted
2023-02-21 08:01:33
Documents
4
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea173981-6k_mainzbio.htm 6-K 15450
2 INTELLECTUAL PROPERTY ASSET PURCHASE AGREEMENT, DATED FEBRUARY 15, 2023, WITH UN ea173981ex10-1_mainzbio.htm EX-10.1 91770
3 ASSIGNMENT AGREEMENT, DATED FEBRUARY 15, 2023, WITH SOCPRA SCIENCES SANTE ET HUM ea173981ex10-2_mainzbio.htm EX-10.2 95468
4 PRESS RELEASE ISSUED FEBRUARY 21, 2023 RE: MAINZ BIOMED ACQUIRES ENTIRE INTELLEC ea173981ex99-1_mainzbio.htm EX-99.1 17136
  Complete submission text file 0001213900-23-013068.txt   220885
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 23645337
SIC: 2834 Pharmaceutical Preparations